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Abstract 
Purpose: To predict activity and reveal the pharmacophore (Pha) with certain electronic and 
topological characteristics for a series of 37 molecules of 4,4′-dihydroxydiphenylmethane, using 4D 
QSAR (four dimensional Quantitative-Structure Activity Relationships) model. 
Methods: We used a computational method called molecular conformer electron topological 
(MCET) for this study. The quality of Pha and the corresponding quantitative model of activity was 
validated (and deemed acceptable) by an independent test set of 7 additional analogs with known 
experimental activities out of 30 molecules of the training set. 
Results: The resulting MCET method demonstrated a high statistical capacity for predicting the 
activity of the molecules under consideration (R2= 0.703 and Q2 = 0.573). 
Conclusion: The model is based on pure computational methods (electronic structure calculations 
and matrix comparisons) and provides the correct solution within the assumptions of the method, 
experimental uncertainty, and computational approximations. A different procedure from other 
QSAR approaches was used to elucidate the interactions between the conformers of the ligand and 
the target protein. 
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Bisphenol A (BPA), which is elected in the 
manufacture of a wide range of consumer 
products, is a prime candidate for endocrine 
disruption [1]. BPA is a monomer composed of 
two unsaturated phenolic rings. The in vitro 
studies proved that BPA binds to the estrogen 
receptors, induces estrogen-dependent gene 
responses [2]. Synthetic endocrine-disrupting 
chemicals (EDCs) bear the possibility to meddle 
in the endocrine system by impersonating 
endogenous hormones such as estrogens and 
androgens [3].  
 
Computational methods establishing QSARs to 
predict activity differences within a set of ligands 
remain a pragmatic alternative. Both classical 
and 3D QSAR methods have been developed as 
ligand based approaches [4]. In 3D QSAR such 
as CoMFA (Comparative Molecular Field 
Analysis) method, steric and electrostatic 
features are essentially virtual interaction 
energies calculated using an appropriate probe 
atom placed at the intersection of a regularly 
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spaced grid surrounding the molecule. It could be 
interpreted as a surrogate representation of the 
binding site [5]. 4D-QSAR is an effective way for 
the identification of Pha in action and nature of 
interactions between conformers of the 
molecules and target protein especially [6-7]. A 
pharmacophore map identifies the bioactive sub-
structure of each active molecule and indicates 
how to align. The Pha map represents 
relationship which types of points match in 
conformations of the compounds, and represents 
the common sub-structure of molecules with 
different structure. In this study the MCET 
method with 4D QSAR is used to identify ligand 
substituents needed for high-RBR (Relative 
Binding Ratio) with ER (estrogen receptor) and 
explain their orientation. This method for ER is 
employed to interpret results from affinity studies, 
and related this information with the design of 
new ligands. This analysis including ER phenolic 
molecules is used to obtain information on 
ligand-receptor interactions that lead to either an 
increase or decrease in ER affinity for similar or 
different molecules. In this paper atomic charge 
and geometric descriptors are used to describe 
molecular structure of bisphenol A analogs and 
MCET model based on that their estrogen 
activities are developed to predict the ligand-




A set of 4,4′-dihydroxydiphenylmethane 
derivatives is collected from the literature along 
with their activity. The collected data are 
presented in Table 1 [8].  
 
Table 1: Specific estrogenic activity of 4,4′-Dihydroxydiphenylmethanes (units/mol) in rats  
                                                
 
Molecule no. 








from Eq 3 
01 H C3H7,C2H5 0.57 0.57 
02 H C3H7, C3H7 0.25 0.57 
03 H i-C4H9, Me -0.03 -0.14 
04 H C3H7, Me -0.11 -0.43 
05 H Et,Et -0.11 0.10 
06 H C4H9, C3H7 -0.17 0.57 
 07 * 2-Me (Et)2CH,H -0.29 -0.38 
08 H Et ,Me -0.38 -0.25 
09 2-Me i-C4H9,H -0.41 -0.45 
10 H CH2C6H5,H -0.46 -0.64 
11 2-Me (C3H7)2CH -0.52 -0.70 
12 2-Me C3H7,H -0.78 -0.74 
 13 * H Me,Me -0.80 -0.82 
14 H C4H9,Me -0.83 -0.02 
15 2-Me i-C3H7,H -0.83 -0.70 
16 2-Me C6H13,H -0.85 -1.04 
17 H C6H5, H -0.87 -0.80 
18 3-Me H,H -1.00 -0.60 
 19 * H C4H9,C4H9 -1.02 -1.51 
20 2-Me Me,H -1.02 -0.78 
21 2-Me Et,H -1.15 -0.93 
 22 * H (C6H5)2CH,H -1.62 -1.15 
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*Test set molecules 
 
 





With respect to the molecular conformations, 
quantum chemical calculations are obtained via 
“Spartan’08” software [9]. In the first step, 
Spartan’s molecular mechanics force field 
(MMFF) is used, because it presently provides 
the calculation of equilibrium geometries, strain 
energies and normal-mode vibrational 
frequencies, as well as searches for 
conformation space for both cyclic and acyclic 
molecules. In the second step, 3-21G(*) is 
selected in Spartan’s Hartree-Fock module which 
provides the calculation of the heat of formation, 
equilibrium and transition-state geometries, the 
charge on each atom and other atomic properties 
[10]. After energy minimizations and molecular 
dynamics calculations are performed, the 
conformers with the lowest energy for each 
molecule were selected as the acceptable 
conformers. These conformers have energies<1 
kcal/mol above the ground state conformation. 
Since acceptable conformers have a larger 
Table 1 (continued): Specific estrogenic activity of 4,4′-Dihydroxydiphenylmethanes (units/mol) in rats  








from Eq 3 
23 H C6H5,Me -1.86 -1.07 
24 3-Me C3H7,C3H7 1.20 1.22 
 25 * 3-Me C3H7,Et -0.63 -0.59 
26 3-Me Et,Et 0.55 0.71 
27 3-Me C4H9,C3H7 0.49 0.37 
28 3-Me C3H7,Me -0.06 0.19 
29 3-Me Me,i-C4H9 -0.22 -0.03 
 30 * 3-Me Me,Me -0.81 -1.51 
31 3-Me Me,Et -0.83 -0.37 
32 3-Me Me,C4H9 -0.87 0.18 
33 3-Me H,i-C4H9 -1.00 -1.02 
 34 * 3-Me C4H9,C4H9 -1.23 -0.70 
35 3-Me Et,H -1.50 -0.62 
36 3-Me Me, C6H5 -1.72 -0.65 
 37 * 3-Me H, C6H13 -1.89 
-1.88 
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population than other conformers, according to 
Boltzmann distribution, if these conformers 
possess Pha, they are more responsible than 
others for activity [11].  
 
Computation of electron topological matrix 
 
We calculate the electronic structure of each 
selected conformation and arrange the 
corresponding electronic and geometrical 
parameters in a matrix k*k (k is the number of 
atoms), called electron topologic matrix (ETM) 
The matrix of acceptable conformers is kept in 
the memory of the computer and processed by 
MCET software which was written using the C# 
programming language by our research group. 
 
The formation of ETM as a language for 
conformer description (one matrix=one 
compound) proceeds in the following way [12]: 
Lets consider Ai be an atom of a conformer being 
described, then the corresponding diagonal 
matrix element aii will be one of m1, which is the 
number of local atomic properties. 
 
If Ai and Aj are any two atoms of the conformer 
then two cases may occur: 
a) Ai and Aj are not chemically bonded. In this 
case the distance between these two atoms 
represents the corresponding non-diagonal 
matrix element aij. 
b) Ai and Aj are chemically bonded, and aij 
describes this bond by means of electronic 
properties (bond length, bond order, bond 
energy, etc.).  
Suppose that we have m2, which is the number 
of such characteristics, then the number of all 
ordinary k*k matrices is m=m1*m2 where is 
dimensional ETM. The matrices, based on the 
data known from quantum chemical calculations, 
can be formed as well as the number of atoms, k, 
in the corresponding conformer. It has been 
assumed that a single electronic matrix in the 
ETM represents a configuration of each 
molecule. The matrix contains charge on the 
diagonal, bond length, and distance on the non-
diagonal, and it is one-dimensional. The ETM of 
N01 in the 4,4′-dihydroxydiphenylmethane series 
is shown in Figure 1. 
 
Pha is commonly defined as an arrangement of 
molecular features or fragments forming a 
necessary but not sufficient condition for 
biological activity [13]. To find Pha, a template 
conformer of active molecule and the acceptable 
conformer of the rest of the molecule set are 
compared as weighted graphs. One conformer of 
a molecule (high active and simple structure) is 
taken as a template, and its ETM is compared 
with the rest of the molecules’ ETMs within 
tolerances [14]. Flexibility limits are quite 
important for the realization of Pha. Larger 
tolerances yield large common submatrices while 
small tolerances give no Pha within the training 
set. Therefore, the issue of tolerances should be 
handled in a delicate manner [11]. 
 
Comparison of Topological Matrices and 
identification of Pha 
 
The ETM is used in both the electron topologic 
(ET) [15-18] and the electron conformer (EC) 
methods [22]. The ET method accounts only one 
conformer with the lowest energy of each ligand 
and emphasizes only Pha for 3D-QSAR analysis. 
Likewise for 4D QSAR analysis, using the 
acceptable conformers of each molecule, the EC 
method takes into account the other side groups 
such as AG and APS besides Pha [11]. While 
Pha is responsible for the existence or non-
existence of activity, APS and AG are 
characteristic variable and responsible for the 
change in activity values of molecules. A criterion 
that is commonly used in structural methods for 
evaluating probable Pha in the series under 
study is represented by the following formulas 
Eq.1: 
 
Pα = ( ν1+1)/( ν1+ ν3+2); αa=( ν1* ν4− ν2* 
ν3)/(μ1* μ2* μ3* μ4)1/2   Eq.1 
 
where ν1 and ν2 are the numbers of molecules 
possessing and not possessing, respectively, the 
feature of activity in the class of molecules; ν3 
and ν4 have analogous meaning in low active 
molecules; and μ1 and μ2 are the numbers of 
molecules in the class of active and low active 
molecules μ3= ν1+ ν3 and μ4= ν2+ ν4. This way 
Pα evaluates only the deposit of active 
molecules, while αa reflects the deposit of both 
active and low active molecules in the feature of 
the activity found. Then, without setting any 
constraints on tolerance values, maximum 
tolerance values are defined for all active 
molecules [19]. 
 
Formula for Quantitative Structure-Activity 
Relationships  
 
After Pha was identified by comparing the ETM 
matrices of conformers, independent variables 
using the properties of atoms acting like AG or 
APS on the ligand were estimated from the 
positions consisting of the defined torsion angles, 
angles, and distances in regard to Pha. The 
adjustable constants of interaction points on the 
receptor, which correspond to all the possible 
positions of the ligand, are calculated by using 
Newton-Raphson approach [20]. 
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Bersuker et al. introduce the function S to take 
into account the independent variables ( (j)nia ) and 








nijni aκS  Eq.2 
where (j)nia  describes the functional group of j
th 
position in the ith conformation of the nth 
molecule and it is also taken as an atomic 
charge. кj (j=1,2…J) indicates the magnitude of 
values at the interaction points of receptor. For 
each of the side groups of J-number used in the 
model, кj is based upon magnitude of the 
corresponding partial least square (PLS) 
regression coefficients, and it is calculated 



















 A  A
 Eq.3 
A0 in Eq. 3is a constant (see below), mnPha and 
mn are numbers of the conformers containing 
Pha and the acceptable conformer, 
respectively. E is the heat of formation; k is 
Boltzmann constant, and T is a room 
temperature. 
 
A reference molecule (ℓ) is chosen from the 
training set, for which the activity is known as Aℓ 





















 A  A
   Eq.4 
It is difficult to find the A0 constant because A0 
constant is not directly determined and known. 
To find A0 we divide Eq.3 by Eq.4 by eliminating 
A0 in the both equations. The following formula 
is used to find the activity prediction through 
different conformations of the same molecule. 
With the knowledge that the activity depends on 
the tolerances in the values of the sub-matrix of 
Pha, we can proceed to find an approximate 
model for the quantitative value of the activity 
using Eq.5. The following conditions will need 
to be fulfilled: 
 Using the Boltzmann distribution formula in 
related to the conformation energy Eni 
 Selecting the conformers possessing Pha, 
 Taking into account values of functional 
groups of each conformer. 
 
Based on these conditions we can calculate the 
activity of the n-th compound by the different 
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The functions of Sni and Sℓi on the right of Eq.5 
are containing substituents such as the AG or 
APS group, are formulated as an exponential 
such as the Boltzmann factor. Boltzmann factor 
is a weighting factor that determines the relative 
probability of a conformer to be in a multi-state 
molecule in thermodynamic equilibrium at 
temperature T.  
 
The MCET is modified in such a similar way to 
the EC, but the applied procedure and the 
computer programming are different from the 
EC. Some of the most important progresses 
and differences in the MCET are the following: 
 
(a) To develop a pharmacophore model, 
several approaches have been proposed [21]. 
The structure of Pha should include at least one 
conformer of an active and simple molecule. If 
there is more than one conformer in the 
template molecule, each of conformers can be 
sequentially used in producing Pha which is a 
common structure for the active molecules. Pha 
used as a useful common template in our 
method is a hypothetical approach, and the 
process of superimposition is based on it. Even 
if there is a different molecular structure, it is 
conformationally directed to assume the shape 
obligatory for its sub-molecular map. The 
superimposition is done for matching of the 
acceptable conformers of other molecules with 
the template conformer. After all possible 
pharmacophores are generated with the 
combination of the atoms of the template 
molecular conformer, the conformers with Pha 
may be aligned and superimposed possible on 
the atoms of Pha with a great degree of 
accuracy. 
 
(b) An algorithm for an automatic extraction of 
the APS and AG variables from the ETM with the 
purpose to evaluate them has not yet found. 
Therefore the extraction has been done 
individually for each conformation. However, 
such an algorithm has been constructed and 
employed in the MCET method, and the 
variables of anij and the values of the 
corresponding parameter of кj in Eq.2 have been 
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simultaneously estimated using Newton-
Raphson approximation [20]. The predicted кj in 
the S function of Eq.5 is controlled by the 
minimization of the variables. The minimization 
can be realized by means of the PLS procedure. 
The predicted кj is determined from the condition 
of minimum of the sum∑ |	An
calc − Anexp	|2, where 
N is the number of molecules in a training set. 
The value of кj obtained in this way characterizes 
the weights of each kind of the ani(j) parameters in 
the overall APS/AG influence [14]. 
 
For many кj-problems, we would need values of 
all the other кj [22] to solve one кj for j = 1, 2,...J. 
Such a calculation requires a self-consistent 
approach as outlined below. 
1. Start with trial кj as number J-1 (except one кi, 
initial value of j equals 1). 
2. To calculate one кj, use the defined value of 
all remained кj. 
3. Solve the Newton-Raphson Equation 
derived from Eq.5 for one кj. 
4. Define the new value of one кj. 
5. Repeat the calculation for another кj coming 
after the defined ones. 
6. Continue iteration until self-consistent results 
for all the кj are obtained, i.e., the activities of 
all molecules do not change from one 
iteration to the next. 
With this approach, all the кj are calculated 
according to Eq.5 to form the 4D QSAR model. 
 
(c) While the CoMFA uses only probes of a 
different charge to pick out the descriptors 
distributed in various regions around the ligand, 
the MCET employs only the atomic properties 
(for example charge, polarizability, HOMO- and 
LUMO-orbital coefficients) to select the 
independent variables oriented around Pha. 
Since the purpose of this study is to identify the 
interaction points of bio-structure in three 
dimensional spaces, the properties of atoms in 
positions interacting with a receptor are used as 
an independent variable. According to the 
variable of distance, angle or dihedral-angle, 
only the positions of atoms in related Pha for all 
conformers can be classified. 
 
d) The positions in Eq.2through GA are 
varied in order to determine the optimal number 
of descriptors [23-24]. GA can not only 
automatically select the optimum number of 
descriptors in linear regression analysis but 
also construct the model of multiple nonlinear 
equations (5), which includes nonlinear 
exponential functions. Therefore, GA is 
employed with linear regression analysis to 
derive and validate the model taken from Eq.5. 
Thus, the relationship between structure and 
activity can be quickly identified from the results 
of the model constructed using MCET. 
 
Results of the model which explain the observed 
biological activity are controlled basing on PLS 
analysis; data fitting for the training set. A 
procedure which involves iterative selection of 
bio-structures can be repeated until squared 
correlation coefficient (Q2) reaches to big value. 
For the test set, model predictive ability is often 
quantified in terms of the predictive squared 
correlation coefficient (R2) which is calculated by 
methods based on some form of sample reuse, 
such as leave-one-out cross-validation (LOO-CV) 
[25]: 
= 1 −
[∑ (	ŷ ) ]/




     (5) 
 
where nTest is the total number of objects in the 
entire test set, ŷi is the predicted value for the ith 
test molecule and yi is observed value and TSS 
is the total sum of squares, that is, the sum of 
squared deviations from the data set mean, and 
PRESS is the sum of squares of the prediction 
errors. Common definition of the parameter Q2 
used for assessing the model fit from the training 
set (TR) objects [25]: 
= 1 −
∑ (	ŷ )
∑ ( ȳ 	)
= 1 −
     (6) 
 
where RSS is the residual sum of squares, that 
is, the sum of the squared deviations between 
experimental and calculated response values 
over the training set. TSS is the total sum of 
squares, which is related to the total response 
variance of the training cases and nTR is the total 




The values and positions of the atoms were 
unique for activities of the molecules under 
consideration. As shown in Figure 1 the sub 
matrix was marked with the bold letter to show 
Pha placed in the ETM of template conformer. 
 
All the conformers containing Pha are matched 
and aligned by placing the coordinate values of 
the first three atoms of Pha using a Cartesian 
coordinate system, providing x1=0; y1=0; z1=0, 
x2=0; y2=0; z2≠0 and x3=0; y3≠0; z3≠0, 
respectively. A Pha needs at least three points of 
connection, but there can be more. A complete 
Pha can be represented geometrically as a 
Yilmaz et al 
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triangle if three points are used; or as some other 
geometric figures if more points are available. To 
compare the compounds with the various 
structures in 3D, first three atoms of Pha 
structure, instead of atoms in the common 
skeleton of compounds, is aligned, and then the 
remaining atoms are again oriented according to 
Pha. After the structural alignment of the 
considered Pha, the functional AG and APS 
groups from several variations of the oriented 
atoms of the molecules were determined by GA, 
and the best statistical results were obtained by 
taking them into account together with Pha. 
Interactions between a receptor and a ligand are 
complex and depend upon the context in which 
the groups of ligands are presented to the 
receptor. These interactions are also more 
responsible for the activity than other factors. 
Local independent variables, which are the 
electronic properties of the oriented atoms 
around Pha, describe the ability of atomic sites 
and fragments to take part mostly in interactions 
dependent upon the present Pha, and 
subsequently should be taken into account for 
the modeling activity. These parameters, 
however, can also be used for assessing the 
propensity of chemicals to take part in weak 
interactions; hence, they are also included in the 
list of parameters available for the description of 
non-specific interactions. Finally, specific 
parameters of Pha between a ligand and a 
receptor have also shown to be critically 
important for deriving mechanistically reasonable 
models. These molecules might become more or 
less active due to their conformations and 
functional groups. As some atoms of the 
conformers in the molecules undergo 
 
 
Table 2: The observed and calculated data related to the molecules of training set understudy 
 
Mol Obs. Calc. The heat of formation (kcal/mol) and AG/APS positions of conformers. 
n01 0.57 0.57 -265.53ab  -265.53abc                
n02 0.25 0.57 -293.78abc -293.78ab                
n03 -0.03 -0.14 -249.41ab  -250.33ab  -249.29ab              
n04 -0.11 -0.43 -247.70ab  -247.70ab  -247.52ab  -247.52ab  §-247.34  §-247.34  §-245.88      
n05 -0.11 0.10 -237.22abc §-237.08  §-236.91              
n06 -0.17 0.57 -322.37abc -322.37ab                
n07* -0.29 -0.38 -311.59ab  -311.42ab  §-311.42  §-311.42  -311.38ab  -311.19ab  §-310.86  -308.53abc -307.49abd 
n08 -0.38 -0.25 -219.46ab  -219.46ab  §-216.31              
n09 -0.41 -0.45 -288.57abc -288.56abc  §-285.65              
n10 -0.46 -0.64  §-90.53   §-90.53   §-90.45  -90.38ab  -89.01ab          
n11 -0.52 -0.70 -370.31abc -370.31abc  -370.08abc  -370.07abc §-370.00  §-369.85  -369.82abc -369.76abc -369.76ab  
n12 -0.78 -0.74 -284.41abc -284.09ab  -284.06abc  §-283.90  -283.76ab  §-283.59  §-283.55  §-283.55  -282.34abc 
n13* -0.80 -0.82 -201.67abd -201.48abd §-201.33              
n14 -0.83 -0.02 -276.29ab  -276.11abd  -276.07abd  §-275.93  -275.67ab  -275.64abc -275.50abd -275.42abd -275.28abd 
n15 -0.80 -0.70 -267.55ab  -267.49ab                
n16 -0.85 -1.04 -370.00abd -369.67abd  §-369.50  §-369.45  -369.45abd -367.92abd -367.41abc -367.01abd -366.69abd 
n17 -0.87 -0.80 -57.14ab  -57.14abcd  §-57.11   §-57.11  -57.11abd -57.10abc  §-57.04  -56.09abc -55.84abc 
n18 -1.00 -0.60 §-223.99  §-222.40  §-222.40  §-222.39  §-222.38  -222.18ab  §-222.17  §-222.16  §-222.16  
n19* -1.02 -1.51 -350.96ab  -350.96abc -350.78abc -350.77abc -350.75abd §-347.61        
n20 -1.02 -0.78 -230.89ab  -230.69ab  -230.23abcd             
n21 -1.15 -0.93 -255.16abc -255.12abcd -254.96abcd §-254.94  -254.89abc         
n22 -1.62 -1.15 -244.12 -244.53abcd -244.57abd -244.45d -244.12abc -244.31abd    
n23 -1.86 -1.07  §-44.53  -44.53abc  -44.47abd   §-44.45  -44.43abc -44.31abd -44.31abd  §-44.31  -44.30ab  
n24 1.20 1.22 -321.77abd §-321.66  §-321.66  §-321.66  §-321.66  §-321.66  §-321.66  §-321.66  §-321.66  
n25* 1.13 -0.59 -295.55b  §-295.32  §-295.32  -295.16ab  -293.52ab  -293.52abc §-293.42  §-293.41  -293.32abd 
n26 0.55 0.71 -267.32abd §-267.08  -266.92abd  §-266.76  -265.28ab  §-265.17  §-265.07  §-264.99    
n27 0.49 0.37 -352.39ab  §-352.16  -352.16ab  -352.15abd §-352.15  -352.00ab  -351.99abd §-351.83  §-351.83  
n28 -0.06 0.19 -277.73abc -277.73abd  §-277.52  -277.50ab  -277.36ab  -277.35abd §-277.21  §-277.18  -276.68abd 
n29 -0.22 -0.03 -280.92ab  -280.67ab  -280.48abd  §-280.35  -280.24abc §-279.95  -279.84ab  §-279.74  -278.88abd 
n30* -0.81 -1.51 -231.71abd -231.50abd -231.34abd §-231.19  -229.68abd §-229.58  -229.49abd §-229.42    
n31 -0.83 -0.37 -249.48ab  -249.44abc  -249.11abd  -249.10ab  -247.84abd §-247.77  §-247.75  §-247.27  -246.42ab  
n32 -0.87 0.18 -306.33abc -305.92abd  §-305.77  -304.95abc §-304.17  §-304.12  -303.38abc -303.17abd -303.14ab  
n33 -1.00 -1.02 -297.07abc -296.82ab  §-296.72  -296.70ab  -296.46abd -295.12abc §-294.92  -294.90ab  §-294.88  
n34* -1.23 -0.70 -380.75abd -380.59abd §-378.84  -378.02abd -378.01abc §-377.78  §-377.78  -377.74ab  -377.74ab  
n35 -1.50 -0.62 -259.47abc -259.45ab  -259.17ab  -259.13ab  §-259.09  §-259.09  -257.82ab  -257.81abc §-257.50  
n36 -1.72 -0.65  §-74.42  -74.42abc  -74.35ab   §-74.32   §-74.24  -74.22abd  §-74.14   §-73.95   §-72.47  
n37* -1.89 -1.88 -374.01abd -372.09abd -372.08abd §-371.82  -371.37abd -371.03ab  -370.23abd     
*Test set molecules. “§”the conformers not possessing Pha. For the conformers possessing Pha, Atomic positions are shown 
with sigins of a, b, c, d. 
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conformational change, they might catch the 
appropriate position affecting the activity. All the 
positions were distinguished from each other 
according to the distance and the dihedral, and 
angle values. The Pha and the functional groups 
of the conformers in these positions were signed 
as symbols a, b, c, etc. 
 
According to the data set shown in Table 2, the 
position of one conformer might be different from 
that of the other conformers. To calculate the 
activity, these groups, together with Pha, were 
used in Eq.5by separating and combining their 
electrostatic and shape fields. 
 
Table 2 presents the experimental and 
theoretical (calculated) activity, the heat of 
formation of the conformers, and the signs of 
each conformer’s positions; conformers not 
possessing Pha were marked with the “§” 
symbol. 
 
Unfortunately, since there were more variables 
than the defined side groups, such as the APS or 
AG, this extensive study of electronic and 
geometric similarity was flawed by the apparent 
incorporation of numerous errors in the molecular 
structure as well as accounting errors in the 
measurements of the activity. In the current 
study, we did a quantitative account of the model 
in order to define the most appropriate AG and 
APS groups together with Pha. For correct 
classification of the positions, these characteristic 
properties, given in Table 4, were then subjected 
to quantitative analyses via multiple linear 
regressions. To demonstrate the receptor-ligand 
interaction, the results in the data set were 
compared with the corresponding MCET. These 
local parameters in this study were composed of 
three different positions affecting the activity and 
were marked with blue circles in Figure 2.  
                        
  
 
Figure 2. Pha (yellow circles) and AG or APS groups 
of a,b,c,d (orange circles) 
Using LOO-CV, κ-values corresponding to the 
interaction points of the receptor were 
simultaneously calculated from the experimental 
activity of the molecules in the training set and 
then used to predict the activity of those in the 
test set. The positioned local atoms in each 
conformer of the ligand contributed differently to 
the activity. According to Eq.2Sni is the sum of 
the multiplication of the κ-value on the receptor 
by the related atomic charge on the ligand; its 
value is changed and affected negatively or 
positively, depending on the signs of the κ-value 
and the atomic charge. A negative value of Sni 
corresponds to exp(-Sni) being greater than 1, 
while a positive value corresponds to Sni being 
less than 1. If the multiplication has the negative 
result, the atom under consideration supports the 
ligand binding, and acts as the AG group; 
otherwise, the positive result impedes the ligand 




According to this approach, the activity of the 
molecule in one row of Table 4 was quantitatively 
calculated in Eq.5 depending on the heat of 
formation of the conformers and the values of the 
atomic charge in the signed positions of each 
conformer. In this way although we could 
calculate the activities, could not easily show the 
attribution of the signed positions in the Table 4. 
Even if it was difficult to show quantitatively the 
contribution of each group to the activity in this 
calculation, we were able to make the following 
qualitative interpretation: If conformers of a 
molecule involved a functional group in only one 
position its activity was to be increase or 
decrease according to the activity. This functional 
group could be interpreted as the AG or the APS, 
respectively. But if there were more than one 
position in the molecule, we were not able to 
determine their effects. In the same way, the 
contribution of a- and b-positions was not defined 
because they were not studied separately in one 
molecule. If some molecules had only one of 
these positions, it was possible to say whether 
they increased or decreased the activity. If any 
position was presented in the conformers of only 
one molecule, the charge of this atom of the 
conformer gave some information about the 
interaction point of the receptor corresponding to 
the position. By comparing the activities of the 
reference molecule (n01) and the nth molecule, it 
might be possible to understand the contribution 
of different groups in these molecules. Increasing 
or decreasing the activities depends on the 
atomic charge in the defined positions. According 
to this approach, we were able to explain the 
contribution of the positions as follows: Since the 
conformers of the molecules such as n01, n02 
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and n06 had the functional groups consisting of 
a-, b- and c-positions together with Pha, their 
activities were calculated as the same value of 
0.57. Since the calculated activities of the 
molecule n03 and n15 were less than that of the 
previous molecules whose all conformers 
possessed a- and b-positions (not c-position), we 
could give information about c-position as a 
reason for different activity between two groups 
of molecules. The atoms of c-position acted as 
an AG in the molecules. For the molecules (n04-
n05, n07-n10 etc.), since some conformers of 
them did not have Pha, their activities should be 
lower than the others. The activities of the 
molecules such as n13-n14 which contain d-
position together with a- and b-positions 
decreased with respect to the activity of the 
reference. It could be interpreted that the atoms 
in the d-position might act as an APS group. 
The 4D-QSAR model was resulted through 30 
ligands in the training set and validated by their 
LOO-CV errors, and was used to predict the 
activity of 7 samples in the test set. The 
relationships between the calculated and 
experimental RBR for molecules in both training 
and test set were shown in Figure 3. 
 
 
Figure 3: Correlation between experimental and 
calculated data sets on estrogenic activity given in 
training set■ and test set* 
 
Using the electronic and geometric properties in 
the conformers, the results obtained from 4D-
QSAR analysis are statically interpreted. The 
study showed that taking into account the 
conformers according to the descriptors (Pha, 
AG and APS) was a useful approach. Only 
topological descriptors were used to produce an 
objective description of the fit. Under these 
conditions it might be assumed that appropriately 
chosen and well-evaluated molecular features 
were unique for the estrogenic activity. The 
defined topological descriptors were indeed 
responsible for the activity and it was well-
established. The model arising from Pha, AG and 
APS was compatible with three dimensional 
structure of the receptor environment, and could 
summarize the information of closely related 
descriptors. The correlations coefficients of the 
model for the training and test set (respectively, 
R
2
= 0.703 and Q2 = 0.573) show that it can be 
useful for computer aided drug design of the 
understudy molecules. In our study, three 
successful strategies of the MCET method were 
designed and applied to build a 4D-QSAR model. 
These are (1) the prediction of activities, (2) a 
simple illustration of the structure-properties 
relationships for the activity; and (3) the 





We have developed the model based on the 
atomic charge of the ligand, and it’s the best-fit 
topology. The model refers to pure computational 
methods (electronic structure calculations and 
matrix comparisons) and provides the correct 
solution (within the assumptions of the method, 
experimental uncertainty, and computational 
approximations). The computational method 
establishing 4D-QSAR in respect to the three-
dimensional orientation of substituents, which 
increase or decrease the activity, in each 
molecular conformer has been analyzed and 
discussed. A different procedure from other 
QSAR approaches was used in the nature of the 
interactions between the conformers of the ligand 
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